SSTR5 antagonist 6, identified by the CAS number 1007836-12-5, is a chemical compound that functions as an antagonist for the somatostatin receptor subtype 5 (SSTR5). This receptor is part of the somatostatin receptor family, which plays a crucial role in various physiological processes, including the regulation of hormone secretion and neurotransmission. Antagonists like SSTR5 antagonist 6 are of interest in pharmacological research, particularly for their potential therapeutic applications in conditions such as neuroendocrine tumors and other disorders influenced by somatostatin signaling. The compound's structure typically features specific functional groups that enable it to bind selectively to the SSTR5 receptor, inhibiting its activity. While detailed physicochemical properties such as solubility, melting point, and specific biological activity may vary, the compound's efficacy and safety profile are essential for its development as a therapeutic agent. Further studies are often required to elucidate its mechanism of action and potential side effects in clinical settings.

SSTR5 antagonist 6

1007836-12-5: SSTR5 antagonist 6, identified by the CAS number 1007836-12-5, is a chemical compound that functions as an antagonist for the somatostatin receptor subtype 5 (SSTR5). This receptor is part of the somatostatin receptor family, which plays a crucial role in various physiological processes, including the regulation of hormone secretion and neurotransmission. Antagonists like SSTR5 antagonist 6 are of interest in pharmacological research, particularly for their potential therapeutic applications in conditions such as neuroendocrine tumors and other disorders influenced by somatostatin signaling. The compound's structure typically features specific functional groups that enable it to bind selectively to the SSTR5 receptor, inhibiting its activity. While detailed physicochemical properties such as solubility, melting point, and specific biological activity may vary, the compound's efficacy and safety profile are essential for its development as a therapeutic agent. Further studies are often required to elucidate its mechanism of action and potential side effects in clinical settings.

<p>SSTR5 antagonist 6, an orally active antagonist specific to the somatostatin receptor subtype 5 (SSTR5), exhibits an IC50 value of 24 nM. This compound is utilized in researching type 2 diabetes [1].</p>

CAS 1007836-12-5

SSTR5 antagonist 6

SSTR5 antagonist 6

Ref: TM-T87442